Two-staged stereotactic radiosurgery for the treatment of patients with brain metastases
Abstract
Hypofractionated stereotactic radiosurgery is an effective method of treating brain metastases, if their size or localization do not allow for their single-fraction irradiation. Differences in treatment regimens and patient populations between studies make it difficult to compare and analyze the results.
THE PURPOSE OF THE STUDY: To evaluate the effectiveness of two-stage Gamma knife stereotactic radiosurgery of brain metastases from various cancers.
MATERIALS AND METHODS: retrospective analysis of the results of two-stage stereotactic radiosurgery of 124 intracranial metastases. Irradiation was carried out on Leksell Gamma Knife Perfexion and Icon installations. The median tumor volume was 11.06 cm3. The marginal dose in the first and second stages was in the range of 10–14 GY, the total focal dose varied from 20 to 28 GY. The interval between the stages was 14 days.
RESULTS. The average follow-up period was 9.4 months. Continued growth was registered in 14.3 % of patients, radiation complications in 4.8 %. Local control of BM at 6, 12 and 24 months was 94 %, 86 %, 83 %, respectively.
CONCLUSION. Two-stage hypofractive stereotactic radiosurgery can be considered as the method of choice in the treatment of a complex category of oncological patients with cerebral metastases in the presence of restrictions to perform single irradiation or microsurgical resection.
About the Authors
O. L. EvdokimovaRussian Federation
Evdokimova Olga Liveryevna
Moscow
V. A. Rak
Russian Federation
Rak Viacheslav Avgustovich
Moscow
A. S. Tokarev
Russian Federation
Tokarev Alexey Sergeevich
Moscow
K. V. Koval
Russian Federation
Koval Konstantin Vladimirovich
Moscow
A. A. Grin
Russian Federation
Grin Andrey Anatolyevich
Moscow
References
1. Ewend, M. G. Current treatment paradigms for the management of patients with brain metastases / M. g. Ewend, S. Elbabaa, L.A. Carey // Neurosurgery.— 2005. — Vol. 57, № 5 Suppl. — S 66–77; Discusssion S 1–4.
2. Stereotactic radiosurgical treatment of brain metastases / J. R. Adler, R. S. Cox, I. Kaplan, D. P. Martin // journal of neurosurgery.— 1992. — Vol. 76, № 3. — p. 444–449.
3. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases / E. Alexander, T. M. Moriarty, R. B. Davis [et al.] // Journal of the National Cancer Institute.— 1995. — Vol. 87, № 1. — p. 34–40.
4. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis / J. C. Flickinger, D. Kondziolka, L. D. Lunsford [et al.] // International journal of radiation oncology, biology, physics.— 1994. — Vol. 28, № 4. — p. 797–802.
5. The radiosurgery fractionation quandary: single fraction or hypofractionation? / J. P. Kirkpatrick, S. G. Soltys, S. S. Lo [et al.] // Neuro-oncology.— 2017. — Vol. 19, № Suppl 2. — ii38–49.
6. The biology of radiosurgery and its clinical applications for brain tumors / D. Kondziolka, S. M. Shin, A. Brunswick [et al.] // Neurooncology.— 2015. — Vol. 17, № 1. — p. 29–44.
7. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis / G. Minniti, E. Clarke, G. Lanzetta [et al.] // Radiation oncology (london, england).— 2011. — Vol. 6. — p. 48.
8. Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin / M.A. Vogelbaum, L. Angelov, S.-Y. Lee [et al.] // Journal of neurosurgery.— 2006. — Vol. 104, № 6. — p. 907–912.
9. Fractionated stereotactic radiosurgery for large brain metastases / R. E. Wegner, J. E. Leeman, P. Kabolizadeh [et al.] // American journal of clinical oncology.— 2015. — Vol. 38, № 2. — p. 135–139.
10. Single-Fraction Versus Multifraction (3 × 9 gy) Stereotactic radiosurgery for large (2 cm) Brain Metastases: a Comparative analysis of local Control and risk of radiation-Induced Brain Necrosis / G. Minniti, C. Scaringi, S. Paolini [et al.] // International journal of radiation oncology, biology, physics.— 2016. — Vol. 95, № 4. — p. 1142–1148.
11. Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases / M.A. Manning, R. M. Cardinale, S. H. Benedict [et al.] // International journal of radiation oncology, biology, physics.— 2000. — Vol. 47, № 3. — p. 603–608.
12. Comparison of treatment results between 3- and 2-stage gamma Knife radiosurgery for large brain metastases: a retrospective multi-institutional study / T. Serizawa, Y. Higuchi, M. Yamamoto [et al.] // Journal of neurosurgery.— 2018. — Vol. 131, № 1. — p. 227–237.
13. Comparison of two-stage gamma Knife radiosurgery outcomes for large brain metastases among primary cancers / D. Ito, K. Aoyagi, O. Nagano [et al.] // Journal of neuro-oncology.— 2020. — Vol. 147, № 1. — p. 237–246.
14. Response assessment criteria for brain metastases: proposal from the RANO group / N. U. Lin, E. Q. Lee, H. Aoyama [et al.] // The lancet oncology.— 2015. — Т. 16, № 6. — e270-e278.
15. Common Terminology Criteria for adverse events (CTCAE) Version 5.0 [electronic resource] — available at: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm#ctc_50
Review
For citations:
Evdokimova O.L., Rak V.A., Tokarev A.S., Koval K.V., Grin A.A. Two-staged stereotactic radiosurgery for the treatment of patients with brain metastases. Russian Neurosurgical Journal named after Professor A. L. Polenov. 2022;14(2):73-76. (In Russ.)